Annovis Bio, Inc. (NYSE:ANVS) Receives $37.00 Consensus Price Target from Brokerages
Annovis Bio, Inc. (NYSE:ANVS – Get Free Report) has earned an average rating of “Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average […]
Annovis Bio, Inc. (NYSE:ANVS – Get Free Report) has earned an average rating of “Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average […]